Abbott Laboratories

NYSE:ABT   3:59:57 PM EDT
122.25
+0.68 (+0.56%)
4:00:00 PM EDT: $122.24 -0.01 (-0.01%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)217.22B
Current PE34.09
Forward PE 27.6
2yr Forward PE 26.23
See more stats
Estimates Current Quarter
Revenue$9.45 Billion
Adjusted EPS$0.93
See more estimates
10-Day MA$120.91
50-Day MA$115.17
200-Day MA$114.75
See more pivots

Abbott Laboratories Stock, NYSE:ABT

100 Abbott Park Road, Abbott Park, Abbott Park, Illinois 60064-6400
United States of America
Phone: +1.224.667.6100
Number of Employees: 109000

Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.